TrialThe New England journal of medicine2018
Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation.
Jennifer K Litton et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1,203 papers cite itlatest 60 shown
this paperpooled ittrialcites it